← Eichor
Study identifier: NCT07245394 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Condition: Inflammatory Bowel Disease (IBD) · Crohn Disease (CD) · Ulcerative Colitis (UC)  ·  Sponsor: TIDHI Innovation Inc.

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The SHIFT-IBD Study is being conducted at multiple medical centers across Canada to evaluate how well guselkumab (Tremfya) works for people with inflammatory bowel disease (IBD) who haven't responded well enough to ustekinumab. Patients will begin guselkumab based on their doctor's decision. If eligible, they may be invited to participate in the study, which involves monitoring symptoms, test results, and overall health over the course of one year. Guselkumab will be given according to local medical guidelines. Doctors can adjust the treatment as needed, just like in routine care. Researchers believe that switching to guselkumab may be as effective as other advanced treatments. For those who saw some improvement on ustekinumab but not enough, guselkumab may offer better symptom control-without worsening results on medical tests like endoscopy. The goal is to explore better treatment options for people whose IBD has not been well controlled with current therapies.

This description comes directly from the study's public registry record.

Talk to the study team

Ajani Jeyakumar, HBSc BScN RN  ·  647-812-2113  ·  ajeyakumar@tidhi.ca

Katy Staikin, MSc  ·  647-812-2113  ·  kstaikin@tidhi.ca

Always discuss trial participation with your own doctor first.

Locations (12)

University of CalgaryCalgary, Alberta, CanadaRecruiting
MA MacMillanFredericton, New Brunswick, CanadaRecruiting
Hamilton Health Sciences CorporationHamilton, Ontaio, CanadaNot Yet Recruiting
Barrie GI AssociatesBarrie, Ontario, CanadaRecruiting
Brampton Gastroenterology Research Group IncBrampton, Ontario, CanadaRecruiting
GNRR Digestive Clinics and Research Center Inc.Brampton, Ontario, CanadaRecruiting
LDDI Clinical Trials Inc. dba London Digestive Disease InstituteLondon, Ontario, CanadaRecruiting
West Gta Research Inc.Mississauga, Ontario, CanadaRecruiting
Abp Research Services CorporationOakville, Ontario, CanadaRecruiting
Taunton Surgical CenterOshawa, Ontario, CanadaRecruiting
Toronto Immune and Digestive Health InstituteToronto, Ontario, CanadaRecruiting
The Research Institute of the McGill University Health CentreMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07245394